Evommune Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Mar '26 Mar 2, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	807	-	-
Enterprise Value	732	-	-
Debt / Equity Ratio	0.01	0.03	0.02
Net Debt / Equity Ratio	-1.02	-1.49	-1.09
Net Debt / EBITDA Ratio	1.06	1.03	2.11
Net Debt / FCF Ratio	0.96	1.21	2.59
Asset Turnover	-	0.09	-
Quick Ratio	7.30	2.58	11.53
Current Ratio	7.87	2.64	11.67
Return on Equity (ROE)	-	-112.09%	-
Return on Assets (ROA)	-	-55.28%	-
Return on Capital Employed (ROCE)	-98.20%	-145.60%	-50.20%
Buyback Yield / Dilution	-22.66%	-20.35%	-

Updated Oct 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q